Authors
- . Fatemeh Taheri 1
- . Ahmad Yaraghi 1
- . Ali Mohammad Sabzghabaee 1
- . Maryam Moudi 2
- . Nastaran Eizadi‑Mood 3
- . Farzad Gheshlaghi 3
- . Ziba Farajzadegan 4
1 isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Biology, University of Putra Malaysia, Malaysia
3 Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Health and Social Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Objective: Methadone poisoning can occur accidentally or intentionally for suicide or
homicide purposes. The aim of this study was to evaluate the epidemiological and clinical
manifestations of Methadone poisoning.
Methods: A descriptive analytical study was performed from 2010 to 2012 in the poisoning
emergency and clinical toxicology departments of Noor hospital affiliated with Isfahan
University of Medical Sciences (Isfahan, Iran). All patients with Methadone poisoning within
this period of time were investigated. Different variables were recorded in a checklist.
Findings: A total of 385 patients were studied. About 85.7% had ingested only Methadone
and 14.3% had ingested other medications with Methadone. Mean ± standard deviation
of the age was 32.1 ± 15 years (range: 1‑90). Most of the patients were male (76.4%).
Nearly 40% of the patients were narcotic addicts, 25.5% were addicts under surveillance of
Methadone maintenance therapy centers and 34.5% were non‑addicts. Intentional poisoning
was observed in most of the patients (57.7%). Most of the patients had a low level of
consciousness on admission (58.2%). Respiratory depression and hypotension was observed
in 35.6% and 12.7% of the cases as the most common symptoms. Regarding vital signs, there
was a significant difference in respiratory rate on admission among different evaluated
groups (P = 0.02). Length of hospital stay was 18.79 ± 0.72 h (range: 4‑240 h, median: 15 h).
About 57 patients (25.8%) from the intentionally poisoned patients and 19 patients (12.3%)
from the unintentionally poisoned patients had a history of psychiatric disorder (P = 0.001).
Most of the patients survived without complications.
Conclusion: Addiction, age, gender, attempt to suicide and a history of psychiatric disorder
were of the most important factors effective in Methadone poisoning, which should be
considered in the public training and prevention of poisoning.
Keywords
of Poisoning and Overdose. Philadelphia: WB Saunders
Company; 1998. p. 505‑19.
2. LoVecchio F, Pizon A, Riley B, Sami A, D’Incognito C. Onset
of symptoms after methadone overdose. Am J Emerg Med
2007;25:57‑9.
3. Wolff K. Characterization of methadone overdose: Clinical
considerations and the scientific evidence. Ther Drug Monit
2002;24:457‑70.
4. Hsu WY, Chiu NY, Liao YC. Rhabdomyolysis and brain
ischemic stroke in a heroin‑dependent male under methadone
maintenance therapy. Acta Psychiatr Scand 2009;120:76‑9.
5. Roland EH, Lockitch G, Dunn HG, Peacock D, Pirie GE.
Methadone poisoning due to accidental contamination of
prescribed medication. Can Med Assoc J 1984;131:1357‑8.
6. Caplehorn JR, Drummer OH. Fatal methadone toxicity: Signs
and circumstances, and the role of benzodiazepines. Aust N
Z J Public Health 2002;26:358‑62.
7. Centers for Disease Control and Prevention (CDC). Overdose
deaths involving prescription opioids among medicaid
enrollees‑Washington, 2004‑2007. MMWR Morb Mortal Wkly
Rep 2009;58:1171‑5.
8. Hon KL, Ho JK, Hung EC, Cheung KL, Ng PC. Poisoning
necessitating pediatric ICU admissions: Size of pupils does
matter. J Natl Med Assoc 2008;100:952‑6.
9. Clausen T, Anchersen K, Waal H. Mortality prior to, during
and after opioid maintenance treatment (OMT): A national
prospective cross‑registry study. Drug Alcohol Depend
2008;94:151‑7.
10. Caplehorn JR. Deaths in the first two weeks of maintenance
treatment in NSW in 1994: Identifying cases of iatrogenic
methadone toxicity. Drug Alcohol Rev 1998;17:9‑17.
11. Afshari R, Maxwell SR, Bateman DN. Hemodynamic
effects of methadone and dihydrocodeine in overdose. Clin
Toxicol (Phila) 2007;45:763‑72.
12. Pilgrim JL, McDonough M, Drummer OH. A review of
methadone deaths between 2001 and 2005 in Victoria,
Australia. Forensic Sci Int 2013;226:216‑22.
13. Mégarbane B, Buisine A, Jacobs F, Résière D, Chevillard L,
Vicaut E, et al. Prospective comparative assessment of
buprenorphine overdose with heroin and methadone: Clinical
characteristics and response to antidotal treatment. J Subst
Abuse Treat 2010;38:403‑7.
14. Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S. The
impact of benzodiazepine use on methadone maintenance
treatment outcomes. J Addict Dis 2008;27:37‑48.
15. McCowan C, Kidd B, Fahey T. Factors associated with
mortality in Scottish patients receiving methadone in primary
care: Retrospective cohort study. BMJ 2009;338:b2225.
16. Bernard JP, Havnes I, Slørdal L, Waal H, Mørland J,
Khiabani HZ. Methadone‑related deaths in Norway. Forensic
Sci Int 2013;224:111‑6.